Development Milestone Payments. Licensee shall pay to Orion non-refundable milestone payments specified below with respect to the development by Licensee of the Recro Product no later than forty-five days (45) after the following events have occurred. Licensee will only pay each of the development milestones listed below once. Milestone Event Milestone Payment Filing of first NDA for a Recro Product with the FDA [* * *] Receipt of Regulatory Approval by FDA with respect to an NDA for a Recro Product [* * *]
Appears in 3 contracts
Samples: License Agreement (Recro Pharma, Inc.), License Agreement (Baudax Bio, Inc.), License Agreement (Recro Pharma, Inc.)
Development Milestone Payments. Licensee shall pay to Orion the following non-refundable development milestone payments specified below with respect to the development by Licensee of the Recro Product no later than fortytwenty-five eight (28) days (45) after the following events have occurred. Licensee will only pay each occurrence of the development milestones listed below once. Milestone Event Milestone Payment Filing of first NDA for a Recro Product with the FDA [* * *] Receipt of Regulatory Approval by FDA with respect to an NDA for a Recro Product [* * *]applicable milestone event:
Appears in 1 contract
